Actively Recruiting
TriClip Japan Post-Approval Study
Led by Abbott Medical Devices · Updated on 2026-04-03
250
Participants Needed
1
Research Sites
197 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational post approval study is to confirm the safety and efficacy of the TriClip System when used in routine clinical practice in the Japanese population and to fulfill post-market requirements following commercial approval in Japan.
CONDITIONS
Official Title
TriClip Japan Post-Approval Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects are eligible to receive the TriClip System per the current approved indications for use (IFU)
- Subjects provide written informed consent prior to conducting any investigation-specific procedures not considered standard of care.
You will not qualify if you...
- There are no exclusion criteria
- Subjects enrolled in the study should not participate in any other therapeutic clinical study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Cerebral & Cardiovascular Center Hospital
Suita, Osaka, Japan, 564-8565
Actively Recruiting
Research Team
J
Jacob Zbinden
CONTACT
M
Meghan Griffin
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here